Price target
6.70RUSD+2.84+73.58%
The 5 analysts offering 1 year price forecasts for Cytek Biosciences, Inc. have a max estimate of 9.00 and a min estimate of 3.50.
Analyst rating
Based on 6 analysts giving stock ratings to Cytek Biosciences, Inc. in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
3
Buy
0
Hold
2
Sell
0
Strong sell
1
EPS
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
−0.045
0.00
0.045
0.090
0.14
Reported
Estimate
Currency: USD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
0.014
−0.0077
0.09
−0.0069
−0.026
0.063
0.12
—
—
—
—
Estimate
0.012
0.022
0.03
−0.025
−0.0029
0.012
0.10
−0.033
−0.017
0.010
0.046
Surprise
+14.74%
−135.07%
+200.00%
+72.32%
−792.50%
+447.26%
+17.81%
—
—
—
—
Revenue
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
0.00
15.00 M
30.00 M
45.00 M
60.00 M
Reported
Estimate
Currency: USD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
49.69 M
48.00 M
58.60 M
44.86 M
46.62 M
51.50 M
57.48 M
—
—
—
—
Estimate
45.71 M
55.48 M
56.58 M
43.59 M
49.53 M
50.70 M
59.38 M
42.66 M
47.79 M
53.32 M
59.81 M
Surprise
+8.71%
−13.48%
+3.57%
+2.92%
−5.87%
+1.59%
−3.21%
—
—
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
CTKB EPS for the last quarter is 0.12 USD despite the estimation of 0.10 USD. In the next quarter EPS is expected to reach −0.03 USD. Track more of Cytek Biosciences, Inc. financials and stay on top of what is up with the company.
In the next quarter Cytek Biosciences, Inc. revenue is expected to reach 42.66 M USD. Check out Cytek Biosciences, Inc. revenue and earnings and make informed decisions.
According to analysts, CTKB price target is 6.70 USD with a max estimate of 9.00 USD and a min estimate of 3.50 USD. Check if this forecast comes true in a year, meanwhile watch Cytek Biosciences, Inc. stock price chart and keep track of the current situation with CTKB news and stock market news.
We've gathered opinions of 6 analysts rating CTKB stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.